MediPharm Labs Corp.
MEDIF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,448 | $11,808 | $10,806 | $12,042 |
| % Growth | -3% | 9.3% | -10.3% | – |
| Cost of Goods Sold | $8,886 | $8,478 | $6,624 | $8,426 |
| Gross Profit | $2,562 | $3,330 | $4,182 | $3,616 |
| % Margin | 22.4% | 28.2% | 38.7% | 30% |
| R&D Expenses | $47 | $46 | $78 | $35 |
| G&A Expenses | $3,359 | $5,793 | $3,480 | $6,091 |
| SG&A Expenses | $4,514 | $7,162 | $4,729 | $4,953 |
| Sales & Mktg Exp. | $1,155 | $1,369 | $1,249 | -$1,138 |
| Other Operating Expenses | $189 | -$78 | -$184 | $431 |
| Operating Expenses | $4,750 | $7,130 | $4,623 | $5,419 |
| Operating Income | -$2,188 | -$3,800 | -$441 | -$1,803 |
| % Margin | -19.1% | -32.2% | -4.1% | -15% |
| Other Income/Exp. Net | $46 | $30 | $54 | $77 |
| Pre-Tax Income | -$2,142 | -$3,770 | -$387 | -$1,726 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,142 | -$3,770 | -$387 | -$1,726 |
| % Margin | -18.7% | -31.9% | -3.6% | -14.3% |
| EPS | -0.01 | -0.009 | -0.001 | -0.004 |
| % Growth | -9.9% | -911.1% | 78.6% | – |
| EPS Diluted | -0.01 | -0.009 | -0.001 | -0.004 |
| Weighted Avg Shares Out | 420,755 | 415,350 | 415,124 | 415,049 |
| Weighted Avg Shares Out Dil | 420,755 | 415,350 | 415,124 | 415,049 |
| Supplemental Information | – | – | – | – |
| Interest Income | $62 | $42 | $70 | $98 |
| Interest Expense | $16 | $12 | $16 | $21 |
| Depreciation & Amortization | $420 | $419 | $425 | $561 |
| EBITDA | -$1,706 | -$3,339 | $54 | -$1,144 |
| % Margin | -14.9% | -28.3% | 0.5% | -9.5% |